SEC Form 4 · accession 0001144204-19-002703

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exec. VP, Corporate Strategy · Director

Period of report

Jan 22, 2019

Accepted (ET)

Jan 24, 2019 · 9:04 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jan 22, 2019	M	2,500	$11.83	A	2,500	D
Class A Common Stock^F2	Jan 22, 2019	S	2,500	$31.40	D	0	D
Class A Common Stock	Jan 23, 2019	M	2,500	$11.83	A	2,500	D
Class A Common Stock^F3	Jan 23, 2019	S	1,910	$31.58	D	590	D
Class A Common Stock^F4	Jan 23, 2019	S	590	$32.18	D	0	D
Class A Common Stock	Jan 24, 2019	M	2,500	$11.83	A	2,500	D
Class A Common Stock^F5	Jan 24, 2019	S	2,500	$31.78	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock	$11.83	Jan 22, 2019	M	2,500	D	Mar 1, 2013	Feb 28, 2019	Class A Common Stock	2,500	14,780	D
Option to purchase Common Stock	$11.83	Jan 23, 2019	M	2,500	D	Mar 1, 2013	Feb 28, 2019	Class A Common Stock	2,500	12,280	D
Option to purchase Common Stock	$11.83	Jan 24, 2019	M	2,500	D	Mar 1, 2014	Feb 28, 2019	Class A Common Stock	2,500	9,780	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.82, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.07, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.21, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.10, inclusive.